Annual SGA
$116.50 M
+$26.19 M+29.00%
December 31, 2023
Summary
- As of February 7, 2025, NTLA annual SGA is $116.50 million, with the most recent change of +$26.19 million (+29.00%) on December 31, 2023.
- During the last 3 years, NTLA annual SGA has risen by +$72.33 million (+163.75%).
- NTLA annual SGA is now at all-time high.
Performance
NTLA SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$30.50 M
-$1.29 M-4.06%
September 30, 2024
Summary
- As of February 7, 2025, NTLA quarterly SGA is $30.50 million, with the most recent change of -$1.29 million (-4.06%) on September 30, 2024.
- Over the past year, NTLA quarterly SGA has increased by +$1.10 million (+3.73%).
- NTLA quarterly SGA is now -4.06% below its all-time high of $31.79 million, reached on June 30, 2024.
Performance
NTLA Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$7.39 B
-$522.28 M-7.61%
September 30, 2024
Summary
- As of February 7, 2025, NTLA TTM SGA is -$7.39 billion, with the most recent change of -$522.28 million (-7.61%) on September 30, 2024.
- Over the past year, NTLA TTM SGA has dropped by -$7.50 billion (-6745.87%).
- NTLA TTM SGA is now -33568.34% below its all-time high of -$21.94 million.
Performance
NTLA TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
NTLA Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +29.0% | +3.7% | -6745.9% |
| 3 y3 years | +163.8% | +63.0% | -10000.0% |
| 5 y5 years | +261.9% | +261.8% | -10000.0% |
NTLA Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +63.9% | -4.1% | +38.0% | -213.4% | at low |
| 5 y | 5-year | at high | +183.7% | -4.1% | +239.8% | -606.3% | at low |
| alltime | all time | at high | +1306.5% | -4.1% | +2647.8% | <-9999.0% | at low |
Intellia Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $30.50 M(-4.1%) | $122.38 M(+0.9%) |
| Jun 2024 | - | $31.79 M(+2.3%) | $121.28 M(+0.9%) |
| Mar 2024 | - | $31.09 M(+7.2%) | $120.14 M(+3.1%) |
| Dec 2023 | $116.50 M(+29.0%) | $28.99 M(-1.4%) | $116.50 M(+4.8%) |
| Sep 2023 | - | $29.40 M(-4.1%) | $111.13 M(+7.0%) |
| Jun 2023 | - | $30.65 M(+11.7%) | $103.87 M(+8.9%) |
| Mar 2023 | - | $27.45 M(+16.2%) | $95.35 M(+5.6%) |
| Dec 2022 | $90.31 M(+27.0%) | $23.63 M(+6.7%) | $90.31 M(+1.7%) |
| Sep 2022 | - | $22.14 M(+0.1%) | $88.79 M(+4.0%) |
| Jun 2022 | - | $22.13 M(-1.2%) | $85.35 M(+6.8%) |
| Mar 2022 | - | $22.40 M(+1.3%) | $79.91 M(+12.4%) |
| Dec 2021 | $71.10 M(+61.0%) | $22.11 M(+18.2%) | $71.10 M(+19.0%) |
| Sep 2021 | - | $18.71 M(+12.2%) | $59.75 M(+15.8%) |
| Jun 2021 | - | $16.68 M(+22.7%) | $51.61 M(+11.1%) |
| Mar 2021 | - | $13.59 M(+26.3%) | $46.45 M(+5.2%) |
| Dec 2020 | $44.17 M(+7.6%) | $10.76 M(+1.9%) | $44.17 M(+4.2%) |
| Sep 2020 | - | $10.57 M(-8.3%) | $42.38 M(+5.3%) |
| Jun 2020 | - | $11.53 M(+1.9%) | $40.25 M(-3.8%) |
| Mar 2020 | - | $11.31 M(+26.0%) | $41.84 M(+1.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | $41.06 M(+27.6%) | $8.98 M(+6.5%) | $41.06 M(+0.7%) |
| Sep 2019 | - | $8.43 M(-35.7%) | $40.79 M(+0.4%) |
| Jun 2019 | - | $13.12 M(+24.5%) | $40.63 M(+15.0%) |
| Mar 2019 | - | $10.53 M(+21.0%) | $35.32 M(+9.7%) |
| Dec 2018 | $32.19 M(+14.9%) | $8.71 M(+5.3%) | $32.19 M(-4.5%) |
| Sep 2018 | - | $8.27 M(+6.0%) | $33.69 M(+8.2%) |
| Jun 2018 | - | $7.80 M(+5.4%) | $31.14 M(+4.8%) |
| Mar 2018 | - | $7.41 M(-27.5%) | $29.70 M(+6.0%) |
| Dec 2017 | $28.02 M(+66.8%) | $10.21 M(+78.8%) | $28.02 M(+22.2%) |
| Sep 2017 | - | $5.71 M(-10.3%) | $22.93 M(+4.6%) |
| Jun 2017 | - | $6.37 M(+11.1%) | $21.92 M(+13.7%) |
| Mar 2017 | - | $5.73 M(+12.0%) | $19.28 M(+14.8%) |
| Dec 2016 | $16.80 M(+102.8%) | $5.12 M(+8.8%) | $16.80 M(+15.9%) |
| Sep 2016 | - | $4.71 M(+26.2%) | $14.49 M(+28.1%) |
| Jun 2016 | - | $3.73 M(+14.9%) | $11.31 M(+8.6%) |
| Mar 2016 | - | $3.25 M(+15.6%) | $10.42 M(+25.8%) |
| Dec 2015 | $8.28 M | $2.81 M(+83.5%) | $8.28 M(+51.3%) |
| Sep 2015 | - | $1.53 M(-46.0%) | $5.47 M(+38.8%) |
| Jun 2015 | - | $2.83 M(+155.2%) | $3.94 M(+255.2%) |
| Mar 2015 | - | $1.11 M | $1.11 M |
FAQ
- What is Intellia Therapeutics annual SGA?
- What is the all time high annual SGA for Intellia Therapeutics?
- What is Intellia Therapeutics annual SGA year-on-year change?
- What is Intellia Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Intellia Therapeutics?
- What is Intellia Therapeutics quarterly SGA year-on-year change?
- What is Intellia Therapeutics TTM SGA?
- What is the all time high TTM SGA for Intellia Therapeutics?
- What is Intellia Therapeutics TTM SGA year-on-year change?
What is Intellia Therapeutics annual SGA?
The current annual SGA of NTLA is $116.50 M
What is the all time high annual SGA for Intellia Therapeutics?
Intellia Therapeutics all-time high annual SGA is $116.50 M
What is Intellia Therapeutics annual SGA year-on-year change?
Over the past year, NTLA annual SGA has changed by +$26.19 M (+29.00%)
What is Intellia Therapeutics quarterly SGA?
The current quarterly SGA of NTLA is $30.50 M
What is the all time high quarterly SGA for Intellia Therapeutics?
Intellia Therapeutics all-time high quarterly SGA is $31.79 M
What is Intellia Therapeutics quarterly SGA year-on-year change?
Over the past year, NTLA quarterly SGA has changed by +$1.10 M (+3.73%)
What is Intellia Therapeutics TTM SGA?
The current TTM SGA of NTLA is -$7.39 B
What is the all time high TTM SGA for Intellia Therapeutics?
Intellia Therapeutics all-time high TTM SGA is -$21.94 M
What is Intellia Therapeutics TTM SGA year-on-year change?
Over the past year, NTLA TTM SGA has changed by -$7.50 B (-6745.87%)